Pipeline/Due Diligence/NeuraLight - round 2
NeuraLight logo

NeuraLight - round 2

NeurologyAIDigital Healthwww.neuralight.com
Stage
Due Diligence
Owner
Jessica Kim
Amount
$15M
Probability
60%
Next Step
Financial DD
SLA
Risk

Company Overview

NeuraLight is building an AI-powered platform that uses ordinary smartphone cameras to detect and monitor neurological diseases such as Parkinson's and ALS through oculometric biomarkers.

Headquarters
Austin, TX, USA
Founded
2020
Stage
Series A
Employees
45

Due Diligence Checklist

60% complete
Checklist ItemOwnerStatusDueNotes
Financial DDAlex MorganCompletedMay 20—
Legal DDRachel GreenBlockedJun 10Missing IP assignment from 2 contractors
Market AnalysisTom LeeCompletedMay 18—
Technology DDSarah JohnsonNot StartedJun 15—
Commercial DDDavid ChenNot StartedJun 20—
Legal blocker detected by Legal Checklist Agent

Missing IP assignment confirmation from two contractors. Workflow paused at DD stage.

Open in Legal →

Resolving advances NeuraLight through DFC → IC → Deal Launch across Pipeline, Deal, and Automations.

Recent Activity

Financial DD report uploaded by Alex Morgan
Legal DD in progress by Rachel Green
Market analysis completed by Tom Lee
Investment Memo Agent drafted initial memo

Team

JK
Jessica Kim
Deal Owner
AM
Alex Morgan
Financial Analyst
RG
Rachel Green
Legal Counsel
TL
Tom Lee
Market Analyst

AI Insights

  • ●Strong market potential and competitive advantage in real-time monitoring.
  • ●Legal DD missing IP assignment confirmation.
  • ●Comparable company median revenue multiple: 3.2x.

Agent proposed insights — awaiting reviewer.

Open Tasks

Review financial modelHigh
Board deck preparationLow

External Links

Connected workspaces for this deal

Round 2 — Salesforce account page available for follow-on rounds.